Spinal Cord Injury Investor Symposium: A venture investor describes what he looks for when investing in the spinal cord injury space
Spinal Cord Injury Investor Symposium: SCI Ventures is philanthropic but has been designed to invest in spinal cord injuries like a VC fund
Spinal Cord Injury Investor Symposium: University of Miami Miller School of Medicine's James Guest on recent advances, and clinical trial design best practices for spinal cord injury
Brian Skorney joins BiotechTV for Analyst Thursdays and breaks down the Sarepta approval and more
The CEO of the London-based life science investment firm Syncona shares his thoughts on the sector
RBC analyst Luca Issi joins BiotechTV for Analyst Thursdays from Boston
Welcoming Amy Brown as BiotechTV's new UK area contributor
Mizuho senior analyst Salim Syed joins BiotechTV for Analyst Thursdays from the New York Stock Exchange
The CEO of FibroBiologics describes the idea of using fibroblasts rather than stem cells for regenerative medicine and chronic diseases
Ali Gorman and Brad Loncar review #ASCO24 key highlights
Backed by the sovereign wealth fund of Abu Dhabi, Mubadala Capital's executive director describes its investment strategy in life sciences
The head of Leaps by Bayer describes this program and how it helps Bayer be at the forefront of innovation
ApexOnco's Madeleine Armstrong gives a recap of #ASCO24 highlights
Oncology expert Paul Rennert gives an update on Aleta Biotherapeutics and previews some targets at #ASCO24
ApexOnco's Jacob Plieth previews #ASCO24
The founder of Portal Innovations talks about investing in and housing biotech startups in non-traditional locations
Wedbush analyst Laura Chico joins BiotechTV for Analyst Thursdays from Chicago
William Blair analyst Matt Phipps joins BiotechTV for Analyst Thursdays from Research Triangle Park, North Carolina
The CEO of the North Carolina Biotechnology Center talks about growing biotech in the state
The Chordoma Foundation in Raleigh is not only a resource for patients, but also works to advance drug development for this rare type of cancer
.png){kind=logo}
